US-based Instem, a provider of information solutions, has announced that its preclinical solution, Provantis, will be deployed by Cephalon, a biopharmaceutical company.
Provantis is claimed to be a modern, integrated Windows-based system for organizations and universities engaged in non-clinical evaluation studies. The solution suite streamlines processes and workflows with straightforward, intuitive functionality for simple and complex studies within a GLP or non-GLP environment.
Sebastien Girault, director of drug safety at Cephalon, said: Instem integrates the documentation aspects of a toxicology laboratory with the powerful data management of Provantis and Oracle that will provide us with real business benefits we can measure. One of the most anticipated areas of improvement is in reporting, where increasing speed and accuracy with a solution that is easy to learn and use will assist us in producing higher quality documents for internal and external use.